IL6 and Duchenne muscular dystrophy: Notably, measuring expression of these cytokines in dystrophic myotubes from DMD patients showed reduced levels of TNFα and IL‐6 upon CYTORexon2,m1Ψ treatment (Figure S2B, Supporting Information).